+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Contrast Enhanced Ultrasound Market Size, Share & Trends Analysis Report by Product (Equipment, Contrast Agents), Type (Non-targeted, Targeted), End-use (Hospitals, Clinics, Ambulatory Diagnostic Centers), Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 130 Pages
  • January 2024
  • Region: Global
  • Grand View Research
  • ID: 5416057
The global contrast enhanced ultrasound market is anticipated to reach USD 2.99 billion by 2030. It is projected to grow at a CAGR of 5.70% from 2024 - 2030. The rising prevalence of chronic disorders such as cardiovascular ailments, cancer, and liver disease, growing geriatric population, and increasing technological advancements in the ultrasound imaging technology are the major factors anticipated to boost the contrast-enhanced ultrasound market growth over the forecast period. Growth in the market is further propelled using contrast-enhanced ultrasound over other imaging modalities like CT and MRI has become more popular due to its lower cost, portability, and lack of ionizing radiation.

The rising prevalence of cardiovascular diseases fueling the market growth. According to the World Health Organization (WHO), an estimated 17.9 million deaths occur each year due to cardiovascular diseases, making it the leading cause of death globally. In 2022, it is expected that there will be an increase in the number of people diagnosed with cardiovascular diseases. This is where contrast-enhanced ultrasound (CEUS) can play a crucial role in helping to detect and monitor these conditions. CEUS uses a contrast agent that enhances the ultrasound image, allowing for better visualization of the heart and blood vessels. It can be used to diagnose conditions such as heart valve disease, aortic aneurysm, and peripheral artery disease.

Furthermore, CEUS is a non-invasive and safe imaging modality that does not use ionizing radiation. This makes it a preferred option over other imaging modalities like CT and MRI, which use ionizing radiation. In 2021, a study published in the Journal of the American College of Cardiology showed that CEUS had high diagnostic accuracy in detecting coronary artery disease compared to other imaging modalities. With its many benefits, CEUS is becoming an increasingly important tool in diagnosing and managing cardiovascular diseases.

Contrast Enhanced Ultrasound Market Report Highlights

  • Based on product, the equipment segment held the largest revenue share in 2023. This can be attributed to the largest installed base of ultrasound imaging technology compatible with CEUS.
  • The contrast agents segment is expected to grow at the fastest CAGR of 6.32% during the forecast period owing to its approval of usage in the liver and pediatric imaging by the FDA.
  • Based on type, the non-targeted segment held the largest revenue share in 2023 as most of the commercially available contrast agents are non-targeted in nature.
  • The hospitals segment held the largest market share in 2023 owing to the increasing number of emergency visits with medical conditions such as abdominal pain, abdominal/thoracic trauma, and cardiac complications
  • The clinics segment is anticipated to witness lucrative CAGR over the forecast period owing to the realization of economic and patient care benefits with the adoption of sonography devices in practice among physicians at primary and secondary care
  • In Asia-Pacific, the market is expected to grow at the fastest CAGR owing to the limited accessibility to advanced CT/MRI imaging modalities such as CT and MRI, and the growing burden of cardiovascular disorders in China and India.


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Type
1.2.3. End-use
1.2.4. Regional Scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.4.5. Details of Primary Research
1.4.5.1. Data for Primary Interviews in North America
1.4.5.2. Data for Primary Interviews in Europe
1.4.5.3. Data for Primary Interviews in Asia-Pacific
1.4.5.4. Data for Primary Interviews in Latin America
1.4.5.5. Data for Primary Interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Type outlook
2.2.3. End-use
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Contrast Enhanced Ultrasound Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of chronic disorders
3.2.1.2. Technological advancements
3.2.1.3. Extension of indications for use
3.2.2. Market restraint analysis
3.2.2.1. Low stability of the contrast agents
3.2.2.2. Procedural complexity
3.2.2.3. Availability of alternatives
3.3. Contrast Enhanced Ultrasound Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
Chapter 4. Contrast Enhanced Ultrasound Market: Product Estimates & Trend Analysis
4.1. Product Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Contrast Enhanced Ultrasound Market by Product Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Equipment
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Contrast Agents
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Contrast Enhanced Ultrasound Market: Type Estimates & Trend Analysis
5.1. Type Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Contrast Enhanced Ultrasound Market by Type Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Non-targeted
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Targeted
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Contrast Enhanced Ultrasound Market: End-use Estimates & Trend Analysis
6.1. End-use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Global Contrast Enhanced Ultrasound Market by End-use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Hospitals
6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. Clinics
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Ambulatory Diagnostic Centers
6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Contrast Enhanced Ultrasound Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.5. North America
7.5.1. U.S.
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. Canada
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Europe
7.6.1. UK
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. Germany
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.6.3. France
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework/reimbursement structure
7.6.3.3. Competitive scenario
7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
7.6.4. Italy
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework/reimbursement structure
7.6.4.3. Competitive scenario
7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.6.5. Spain
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework/reimbursement structure
7.6.5.3. Competitive scenario
7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.6.6. Norway
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework/reimbursement structure
7.6.6.3. Competitive scenario
7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.6.7. Sweden
7.6.7.1. Key country dynamics
7.6.7.2. Regulatory framework/reimbursement structure
7.6.7.3. Competitive scenario
7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.6.8. Denmark
7.6.8.1. Key country dynamics
7.6.8.2. Regulatory framework/reimbursement structure
7.6.8.3. Competitive scenario
7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Asia-Pacific
7.7.1. Japan
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. China
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. India
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
7.7.4. Australia
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.7.5. South Korea
7.7.5.1. Key country dynamics
7.7.5.2. Regulatory framework/reimbursement structure
7.7.5.3. Competitive scenario
7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.7.6. Thailand
7.7.6.1. Key country dynamics
7.7.6.2. Regulatory framework/reimbursement structure
7.7.6.3. Competitive scenario
7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Key country dynamics
7.8.1.2. Regulatory framework/reimbursement structure
7.8.1.3. Competitive scenario
7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.8.2. Mexico
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework/reimbursement structure
7.8.2.3. Competitive scenario
7.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.8.3. Argentina
7.8.3.1. Key country dynamics
7.8.3.2. Regulatory framework/reimbursement structure
7.8.3.3. Competitive scenario
7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. Key country dynamics
7.9.1.2. Regulatory framework/reimbursement structure
7.9.1.3. Competitive scenario
7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.9.2. Saudi Arabia
7.9.2.1. Key country dynamics
7.9.2.2. Regulatory framework/reimbursement structure
7.9.2.3. Competitive scenario
7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.9.3. UAE
7.9.3.1. Key country dynamics
7.9.3.2. Regulatory framework/reimbursement structure
7.9.3.3. Competitive scenario
7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.9.4. Kuwait
7.9.4.1. Key country dynamics
7.9.4.2. Regulatory framework/reimbursement structure
7.9.4.3. Competitive scenario
7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, by Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.3.4. Lantheus Medical Imaging, Inc.
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. GE Healthcare
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Bracco Diagnostic
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. GE HealthCare
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Siemens Healthcare GmbH
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Koninklijke Philips N.V.
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. CANON MEDICAL SYSTEMS CORPORATION
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 North America contrast enhanced ultrasound market, by region, 2018-2030 (USD Million)
Table 3 North America contrast enhanced ultrasound market, by product, 2018-2030 (USD Million)
Table 4 North America contrast enhanced ultrasound market, by type, 2018-2030 (USD Million)
Table 5 North America contrast enhanced ultrasound market, by end-use, 2018-2030 (USD Million)
Table 6 U.S. contrast enhanced ultrasound market, by product, 2018-2030 (USD Million)
Table 7 U.S. contrast enhanced ultrasound market, by type, 2018-2030 (USD Million)
Table 8 U.S. contrast enhanced ultrasound market, by end-use, 2018-2030 (USD Million)
Table 9 Canada contrast enhanced ultrasound market, by product, 2018-2030 (USD Million)
Table 10 Canada contrast enhanced ultrasound market, by type, 2018-2030 (USD Million)
Table 11 Canada contrast enhanced ultrasound market, by end-use, 2018-2030 (USD Million)
Table 12 Europe contrast enhanced ultrasound market, by region, 2018-2030 (USD Million)
Table 13 Europe contrast enhanced ultrasound market, by product, 2018-2030 (USD Million)
Table 14 Europe contrast enhanced ultrasound market, by type, 2018-2030 (USD Million)
Table 15 Europe contrast enhanced ultrasound market, by end-use, 2018-2030 (USD Million)
Table 16 Germany contrast enhanced ultrasound market, by product, 2018-2030 (USD Million)
Table 17 Germany contrast enhanced ultrasound market, by type, 2018-2030 (USD Million)
Table 18 Germany contrast enhanced ultrasound market, by end-use, 2018-2030 (USD Million)
Table 19 UK contrast enhanced ultrasound market, by product, 2018-2030 (USD Million)
Table 20 UK contrast enhanced ultrasound market, by type, 2018-2030 (USD Million)
Table 21 UK contrast enhanced ultrasound market, by end-use, 2018-2030 (USD Million)
Table 22 France contrast enhanced ultrasound market, by product, 2018-2030 (USD Million)
Table 23 France contrast enhanced ultrasound market, by type, 2018-2030 (USD Million)
Table 24 France contrast enhanced ultrasound market, by end-use, 2018-2030 (USD Million)
Table 25 Italy contrast enhanced ultrasound market, by product, 2018-2030 (USD Million)
Table 26 Italy contrast enhanced ultrasound market, by type, 2018-2030 (USD Million)
Table 27 Italy contrast enhanced ultrasound market, by end-use, 2018-2030 (USD Million)
Table 28 Spain contrast enhanced ultrasound market, by product, 2018-2030 (USD Million)
Table 29 Spain contrast enhanced ultrasound market, by type, 2018-2030 (USD Million)
Table 30 Spain contrast enhanced ultrasound market, by end-use, 2018-2030 (USD Million)
Table 31 Denmark contrast enhanced ultrasound market, by product, 2018-2030 (USD Million)
Table 32 Denmark contrast enhanced ultrasound market, by type, 2018-2030 (USD Million)
Table 33 Denmark contrast enhanced ultrasound market, by end-use, 2018-2030 (USD Million)
Table 34 Sweden contrast enhanced ultrasound market, by product, 2018-2030 (USD Million)
Table 35 Sweden contrast enhanced ultrasound market, by type, 2018-2030 (USD Million)
Table 36 Sweden contrast enhanced ultrasound market, by end-use, 2018-2030 (USD Million)
Table 37 Norway contrast enhanced ultrasound market, by product, 2018-2030 (USD Million)
Table 38 Norway contrast enhanced ultrasound market, by type, 2018-2030 (USD Million)
Table 39 Norway contrast enhanced ultrasound market, by end-use, 2018-2030 (USD Million)
Table 40 Asia-Pacific contrast enhanced ultrasound market, by region, 2018-2030 (USD Million)
Table 41 Asia-Pacific contrast enhanced ultrasound market, by product, 2018-2030 (USD Million)
Table 42 Asia-Pacific contrast enhanced ultrasound market, by type, 2018-2030 (USD Million)
Table 43 Asia-Pacific contrast enhanced ultrasound market, by end-use, 2018-2030 (USD Million)
Table 44 China contrast enhanced ultrasound market, by product, 2018-2030 (USD Million)
Table 45 China contrast enhanced ultrasound market, by type, 2018-2030 (USD Million)
Table 46 China contrast enhanced ultrasound market, by end-use, 2018-2030 (USD Million)
Table 47 Japan contrast enhanced ultrasound market, by product, 2018-2030 (USD Million)
Table 48 Japan contrast enhanced ultrasound market, by type, 2018-2030 (USD Million)
Table 49 Japan contrast enhanced ultrasound market, by end-use, 2018-2030 (USD Million)
Table 50 India contrast enhanced ultrasound market, by product, 2018-2030 (USD Million)
Table 51 India contrast enhanced ultrasound market, by type, 2018-2030 (USD Million)
Table 52 India contrast enhanced ultrasound market, by end-use, 2018-2030 (USD Million)
Table 53 South Korea contrast enhanced ultrasound market, by product, 2018-2030 (USD Million)
Table 54 South Korea contrast enhanced ultrasound market, by type, 2018-2030 (USD Million)
Table 55 South Korea contrast enhanced ultrasound market, by end-use, 2018-2030 (USD Million)
Table 56 Australia contrast enhanced ultrasound market, by product, 2018-2030 (USD Million)
Table 57 Australia contrast enhanced ultrasound market, by type, 2018-2030 (USD Million)
Table 58 Australia contrast enhanced ultrasound market, by end-use, 2018-2030 (USD Million)
Table 59 Thailand contrast enhanced ultrasound market, by product, 2018-2030 (USD Million)
Table 60 Thailand contrast enhanced ultrasound market, by type, 2018-2030 (USD Million)
Table 61 Thailand contrast enhanced ultrasound market, by end-use, 2018-2030 (USD Million)
Table 62 Latin America contrast enhanced ultrasound market, by product, 2018-2030 (USD Million)
Table 63 Latin America contrast enhanced ultrasound market, by type, 2018-2030 (USD Million)
Table 64 Latin America Non-targeted market, by end-use, 2018-2030 (USD Million)
Table 65 Latin America market, by end-use, 2018-2030 (USD Million)
Table 66 Latin America Targeted market, by end-use, 2018-2030 (USD Million)
Table 67 Latin America contrast enhanced ultrasound market, by end-use, 2018-2030 (USD Million)
Table 68 Brazil contrast enhanced ultrasound market, by product, 2018-2030 (USD Million)
Table 69 Brazil contrast enhanced ultrasound market, by type, 2018-2030 (USD Million)
Table 70 Brazil Non-targeted market, by end-use, 2018-2030 (USD Million)
Table 71 Brazil market, by end-use, 2018-2030 (USD Million)
Table 72 Brazil Targeted market, by end-use, 2018-2030 (USD Million)
Table 73 Brazil contrast enhanced ultrasound market, by end-use, 2018-2030 (USD Million)
Table 74 Mexico contrast enhanced ultrasound market, by product, 2018-2030 (USD Million)
Table 75 Mexico contrast enhanced ultrasound market, by type, 2018-2030 (USD Million)
Table 76 Mexico Non-targeted market, by end-use, 2018-2030 (USD Million)
Table 77 Mexico market, by end-use, 2018-2030 (USD Million)
Table 78 Mexico Targeted market, by end-use, 2018-2030 (USD Million)
Table 79 Mexico contrast enhanced ultrasound market, by end-use, 2018-2030 (USD Million)
Table 80 Argentina contrast enhanced ultrasound market, by product, 2018-2030 (USD Million)
Table 81 Argentina contrast enhanced ultrasound market, by type, 2018-2030 (USD Million)
Table 82 Argentina Non-targeted market, by end-use, 2018-2030 (USD Million)
Table 83 Argentina market, by end-use, 2018-2030 (USD Million)
Table 84 Argentina Targeted market, by end-use, 2018-2030 (USD Million)
Table 85 Argentina contrast enhanced ultrasound market, by end-use, 2018-2030 (USD Million)
Table 86 MEA contrast enhanced ultrasound market, by region, 2018-2030 (USD Million)
Table 87 MEA contrast enhanced ultrasound market, by product, 2018-2030 (USD Million)
Table 88 MEA contrast enhanced ultrasound market, by type, 2018-2030 (USD Million)
Table 89 MEA contrast enhanced ultrasound market, by end-use, 2018-2030 (USD Million)
Table 90 South Africa contrast enhanced ultrasound market, by product, 2018-2030 (USD Million)
Table 91 South Africa contrast enhanced ultrasound market, by type, 2018-2030 (USD Million)
Table 92 South Africa contrast enhanced ultrasound market, by end-use, 2018-2030 (USD Million)
Table 93 Saudi Arabia contrast enhanced ultrasound market, by product, 2018-2030 (USD Million)
Table 94 Saudi Arabia contrast enhanced ultrasound market, by type, 2018-2030 (USD Million)
Table 95 Saudi Arabia contrast enhanced ultrasound market, by end-use, 2018-2030 (USD Million)
Table 96 UAE contrast enhanced ultrasound market, by product, 2018-2030 (USD Million)
Table 97 UAE contrast enhanced ultrasound market, by type, 2018-2030 (USD Million)
Table 98 UAE contrast enhanced ultrasound market, by end-use, 2018-2030 (USD Million)
Table 99 Kuwait contrast enhanced ultrasound market, by product, 2018-2030 (USD Million)
Table 100 Kuwait contrast enhanced ultrasound market, by type, 2018-2030 (USD Million)
Table 101 Kuwait contrast enhanced ultrasound market, by end-use, 2018-2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Contrast enhanced ultrasound market: market outlook
Fig. 14 Contrast enhanced ultrasound market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Contrast enhanced ultrasound market driver impact
Fig. 20 Contrast enhanced ultrasound market restraint impact
Fig. 21 Contrast enhanced ultrasound market strategic initiatives analysis
Fig. 22 Contrast enhanced ultrasound market: Product movement analysis
Fig. 23 Contrast enhanced ultrasound market: Product outlook and key takeaways
Fig. 24 Equipment market estimates and forecast, 2018-2030
Fig. 25 Contrast agents estimates and forecast, 2018-2030
Fig. 26 Contrast enhanced ultrasound market: Type movement Analysis
Fig. 27 Contrast enhanced ultrasound market: Type outlook and key takeaways
Fig. 28 Non-targeted market estimates and forecasts, 2018-2030
Fig. 29 Targeted market estimates and forecasts,2018-2030
Fig. 30 Contrast enhanced ultrasound market: end-use movement analysis
Fig. 31 Contrast enhanced ultrasound market: end-use outlook and key takeaways
Fig. 32 Hospitals market estimates and forecasts, 2018-2030
Fig. 33 Clinics market estimates and forecasts,2018-2030
Fig. 34 Ambulatory diagnostic centers market estimates and forecasts, 2018-2030
Fig. 35 Global contrast enhanced ultrasound market: Regional movement analysis
Fig. 36 Global contrast enhanced ultrasound market: Regional outlook and key takeaways
Fig. 37 Global contrast enhanced ultrasound market share and leading players
Fig. 38 North America market share and leading players
Fig. 39 Europe market share and leading players
Fig. 40 Asia-Pacific market share and leading players
Fig. 41 Latin America market share and leading players
Fig. 42 Middle East & Africa market share and leading players
Fig. 43 North America: SWOT
Fig. 44 Europe SWOT
Fig. 45 Asia-Pacific SWOT
Fig. 46 Latin America SWOT
Fig. 47 MEA SWOT
Fig. 48 North America
Fig. 49 North America market estimates and forecasts, 2018-2030
Fig. 50 U.S.
Fig. 51 U.S. market estimates and forecasts, 2018-2030
Fig. 52 Canada
Fig. 53 Canada market estimates and forecasts, 2018-2030
Fig. 54 Europe
Fig. 55 Europe market estimates and forecasts, 2018-2030
Fig. 56 UK
Fig. 57 UK market estimates and forecasts, 2018-2030
Fig. 58 Germany
Fig. 59 Germany market estimates and forecasts, 2018-2030
Fig. 60 France
Fig. 61 France market estimates and forecasts, 2018-2030
Fig. 62 Italy
Fig. 63 Italy market estimates and forecasts, 2018-2030
Fig. 64 Spain
Fig. 65 Spain market estimates and forecasts, 2018-2030
Fig. 66 Denmark
Fig. 67 Denmark market estimates and forecasts, 2018-2030
Fig. 68 Sweden
Fig. 69 Sweden market estimates and forecasts, 2018-2030
Fig. 70 Norway
Fig. 71 Norway market estimates and forecasts, 2018-2030
Fig. 72 Asia-Pacific
Fig. 73 Asia-Pacific market estimates and forecasts, 2018-2030
Fig. 74 China
Fig. 75 China market estimates and forecasts, 2018-2030
Fig. 76 Japan
Fig. 77 Japan market estimates and forecasts, 2018-2030
Fig. 78 India
Fig. 79 India market estimates and forecasts, 2018-2030
Fig. 80 Thailand
Fig. 81 Thailand market estimates and forecasts, 2018-2030
Fig. 82 South Korea
Fig. 83 South Korea market estimates and forecasts, 2018-2030
Fig. 84 Australia
Fig. 85 Australia market estimates and forecasts, 2018-2030
Fig. 86 Latin America
Fig. 87 Latin America market estimates and forecasts, 2018-2030
Fig. 88 Brazil
Fig. 89 Brazil market estimates and forecasts, 2018-2030
Fig. 90 Mexico
Fig. 91 Mexico market estimates and forecasts, 2018-2030
Fig. 92 Argentina
Fig. 93 Argentina market estimates and forecasts, 2018-2030
Fig. 94 Middle East and Africa
Fig. 95 Middle East and Africa market estimates and forecasts, 2018-2030
Fig. 96 South Africa
Fig. 97 South Africa market estimates and forecasts, 2018-2030
Fig. 98 Saudi Arabia
Fig. 99 Saudi Arabia market estimates and forecasts, 2018-2030
Fig. 100 UAE
Fig. 101 UAE market estimates and forecasts, 2018-2030
Fig. 102 Kuwait
Fig. 103 Kuwait market estimates and forecasts, 2018-2030
Fig. 104 Market share of key market players- Contrast enhanced ultrasound market

Companies Mentioned

  • Lantheus Medical Imaging, Inc.
  • GE Healthcare
  • Bracco Diagnostic
  • GE HealthCare
  • Siemens Healthcare GmbH
  • Koninklijke Philips N.V.
  • CANON MEDICAL SYSTEMS CORPORATION
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Methodology

Loading
LOADING...

Table Information